oxaliplatin [Oxaliplatin]
- Termíny
-
Eloxatin
oxaliplatina
-
1,2-Diaminocyclohexane Platinum Oxalate
1,2-Diamminocyclohexane(trans-1)oxolatoplatinum(II)
ACT 078
ACT-078
Cis-oxalato-(trans-l)-1,2-diaminocyclohexane-platinum(II)
Eloxatin
Eloxatine
L-OHP Cpd
Oxalato-(1,2-cyclohexanediamine)platinum II
Oxaliplatin, (SP-4-2-(1R-trans))-isomer
Oxaliplatin, (SP-4-2-(1S-trans))-isomer
Oxaliplatin, (SP-4-3-(cis))-isomer
Oxaliplatine
Platinum(2+) ethanedioate (1R,2R)-1,2-cyclohexanediamine (1:1:1)
Platinum(II)-1,2-cyclohexanediamine Oxalate
An organoplatinum complex in which the platinum atom is complexed with 1,2-diaminocyclohexane, and with an oxalate ligand which is displaced to yield active oxaliplatin derivatives. These derivatives form inter- and intra-strand DNA crosslinks that inhibit DNA replication and transcription. Oxaliplatin is an antineoplastic agent that is often administered with FLUOROURACIL and FOLINIC ACID in the treatment of metastatic COLORECTAL NEOPLASMS.
- DUI
- D000077150 MeSH Prohlížeč
- CUI
- M0095550
- Historická pozn.
- 2019 (1981)
- Veřejná pozn.
- 2019; OXALIPLATIN was indexed under ORGANOPLATINUM COMPOUNDS 1981-2018
Povolená podhesla
- AG
- agonisté 0
- AA
- analogy a deriváty 0
- AN
- analýza 1
- AI
- antagonisté a inhibitory 0
- AD
- aplikace a dávkování 3
- CS
- chemická syntéza 0
- CH
- chemie 2
- HI
- dějiny 0
- EC
- ekonomika 0
- PK
- farmakokinetika 1
- PD
- farmakologie 9
- IM
- imunologie 0
- IP
- izolace a purifikace 1
- CL
- klasifikace 0
- BL
- krev 0
- ME
- metabolismus 0
- UR
- moč 0
- CF
- mozkomíšní mok 0
- ST
- normy 0
- PO
- otrava 0
- AE
- škodlivé účinky 6
- TU
- terapeutické užití 15
- TO
- toxicita 1
- RE
- účinky záření 0
- SD
- zásobování a distribuce 0